Access to treatments, Policy and campaigning
This week’s update on our fast moving community campaign for access to givinostat
Read More
Access to treatments, DMD research
MHRA approves givinostat for all people with DMD aged 6 and older
Read More
Access to treatments, Policy and campaigning
The latest on our fast moving and passionate campaign for access to givinostat
Read More
Access to treatments, DMD research
New medicine for DMD, funded by Duchenne UK and patient groups, becomes first approved treatment in the UK for all patients with DMD
Read More
Access to treatments, Policy and campaigning
Time is muscle: an update on our fast moving campaign for access to givinostat
Read More
Access to treatments, Policy and campaigning
Our campaign for the Early Access Programme for givinostat
Read More
Access to treatments, Policy and campaigning
Update on the givinostat Early Access Programme
Read More
Access to treatments, Policy and campaigning
Early Access Programme for givinostat now open in UK
Read More